The significance of anti-sialyl-Tn antibodies in patients with colorectal and breast cancer

Neoplasma

Volumn 45, Issue 1, 1998, Pages 12-16

  Coomber, D W J ^a   Hawkins, N J ^b   Dalley, D ^a   Ward, R L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Breast neoplasms; Colorectal neoplasms; Serum antibodies; Sialyl Tn

Indexed keywords

ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; MUCIN; SIALIC ACID; SIALIDASE; TUMOR ANTIGEN;

ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; METASTASIS;

EID: 0031981469     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BEN-MARHEZ, K., SOROKINE, I., THIERRY, D., KAWASUMI, T., ISHII, S., SALMON, R., KOHIYAMA, M.: Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients. Int. J. Cancer, 46, 1990, 35-38.
2. COOMBER, D., HAWKINS, N., CLARK, M., MEAGHER, A., WARD, R.: Characterisation and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer. J. Cancer Res. Clin. Oncol., 122, 1996, 757-762.
3. CRAWFORD, L. V., PIM, D.C., BULBROOK, R.D.: Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int. J. Cancer, 30, 1982, 403-408.
4. DAVIDOFF, A.M., IGLEHART, J.D., MARKS, J.R.: Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. Natl. Acad. Sci. USA, 89, 1992, 3439-3442.
5. DESAI, P.R., TEGTMEYER, H., SPRINGER, G.F., METCALFE, S., SWENNSEN, R.J.: Intestinal flora, carcinomata and erythrocytes evoke anti-Tn antibodies. Naturwissenschaften, 74, 1987, 247-248.
6. DEVINE, P.L., BIRRELL, G.W., QUIN, R.J., SHIELD, P.W.: Monoclonal antibodies recognising sialyl-Tn: Production and application to immunochemistry. Dis. Markers, 12, 1995, 175-186.
7. DISIS, M.L., CALENOFF, E., MCLAUGHLIN, G., MURPHY, A.E., CHEN, W., GRONER, B., JESCHKE, M., LYDON, N., MCGLYNN, E., LIVINGSTON, R.B. et al.: Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res., 54, 1994, 16-20.
8. HAKOMORI, S.: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Review. Adv. Cancer Res., 52, 1989, 257-331.
9. ITZKOWITZ, S.H., BLOOM, E.J., KOKAL, W.A., MODIN, G., HAKOMORI, S., KIM, Y.S.: Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer, 66, 1990, 1960-1966.
10. ITZKOWITZ, S.H., YUAN, M., MONTGOMERY, C.K., KJELDSEN, T., TAKAHASHI, H.K., BIGBEE, W.L., KIM, Y.S.: Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res., 49, 1989, 197-204.
11. KJELDSEN, T., CLAUSEN, H., HIROHASHI, S., OGAWA, T., IUIMA, H., HAKOMORI, S.: Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res., 48, 1988, 2214-2220.
12. KOTERA, Y., FONTENOT, J.D., PECHER, G., METZGAR, R.S., FINN, O.J.: Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res., 54, 1994, 2856-2860.
13. KUROSAKA, A., KITAGAWA, H., FUKUI, S., NUMATA, Y., NAKADA, H., FUNAKOSHI, I., KAWASAKI, T., OGAWA, T., IUIMA, H., YAMASHINA, I.: A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAc alpha(2-6)GalNAc, in mucin-type glycoproteins. J. Biol. Chem., 263, 1988, 8724-8726.
14. LONGENECKER, B.M., REDDISH, M., KOGANTY, R., MACLEAN, G.D.: Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis. Adv. Exp. Med. Biol., 353, 1994, 105-124.
15. MILES, D.W., TOWLSON, K.E., GRAHAM, R., REDDISH, M., LONGENECKER, B.M., TAYLOR-PAPADIMITRIOU, J., RUBENS, R.D.: A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer. Br. J. Cancer, 74, 1996, 1292-1296.
16. PUPA, S.M., MENARD, S., ANDREOLA, S., COLNAGHI, M.I.: Antibody response against the c-erbB-2 oricoprotein in breast carcinoma patients. Cancer Res., 53, 1993, 5864-5866.
17. REDDISH, M.A., MACLEAN, G.D., POPPEMA, S., BERG, A., LONGENECKER, B.M.: Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy. Cancer Immunol., Immunother., 42, 1996, 303-309.
18. SOROKINE, I., BEN, M.K., BRACONE, A., THIERRY, D., ISHII, S., IMAMOTO, F., KOHIYAMA, M.: Presence of circulating anti-c-myb oncogene product antibodies in human sera. Int. J. Cancer, 47, 1991, 665-669.
19. SPRINGER, G.F.: T and Tn, general carcinoma autoantigens. Science, 224, 1984, 1198-1206.
20. SPRINGER, G.F., DESAI, P.R., SCANLON, E.F.; Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them. Cancer, 37, 1976, 169-176.
21. SPRINGER, G.F., MURTHY, M.S., DESAI, P.R., SCANLON, E.F.: Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen. Cancer, 45, 1980, 2949-2954.
22. TAKAHASHI, H.K., METOKI, R., HAKOMORI, S.: Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. Cancer Res., 48, 1988, 4361-4367.
23. TSUJI, T., OSAWA, T., Carbohydrate structure of bovine submaxillary mucin. Carbohydrate Res., 151, 1986, 391-402.
24. WINTER, S.F., MINNA, J.D., JOHNSON, B.E., TAKAHASHI, T., GAZDAR, A.F., CARBONE, D.P.: Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res., 52, 1992, 4168-4174.
25. YUAN, M., ITZKOWITZ, S.H., BOLAND, C.R., KIM, Y.D., TOMITA, J.T., PALEKAR, A., BENNINGTON, J.L., TRUMP, B.F., KIM, Y.S.: Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res., 46, 1986, 4841-4847.